Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

NCT05729646 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Stomach
Adenocarcinoma of Esophagogastric Junction
Mismatch Repair Deficiency

Interventions

DRUG: Toripalimab
DRUG: Oxaliplatin
DRUG: S1

Sponsor

Yu jiren